Clinical Trials
15
Active:0
Completed:8
Trial Phases
3 Phases
Early Phase 1:1
Phase 4:4
Not Applicable:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Not Applicable
5 (50.0%)Phase 4
4 (40.0%)Early Phase 1
1 (10.0%)Efficacy of Kera Sol Tears on Signs and Symptoms of Surgical Temporary Ocular Discomfort Syndrome (STODS) in Subjects Following LASIK
Not Applicable
Recruiting
- Conditions
- Dry Eye
- Interventions
- Drug: Kera Sol Eye Drops
- First Posted Date
- 2025-09-04
- Last Posted Date
- 2025-09-11
- Lead Sponsor
- Vance Thompson Vision
- Target Recruit Count
- 60
- Registration Number
- NCT07155070
- Locations
- 🇺🇸
Vance Thompson Vision Clinic, Prof. LLC, Sioux Falls, South Dakota, United States
A Prospective, Single-Arm Study Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of Dry Eye Disease in Patients Undergoing Refractive Cataract Surgery
Not Applicable
Not yet recruiting
- Conditions
- Dry Eye Disease (DED)
- First Posted Date
- 2025-09-04
- Last Posted Date
- 2025-09-04
- Lead Sponsor
- Vance Thompson Vision
- Target Recruit Count
- 60
- Registration Number
- NCT07155057
Refractive and Visual Outcomes With the ARGOS Biometer In Eyes With a History of Refractive Surgery: ARGOS Study
Completed
- Conditions
- Cataract
- First Posted Date
- 2025-08-19
- Last Posted Date
- 2025-08-24
- Lead Sponsor
- Vance Thompson Vision
- Target Recruit Count
- 20
- Registration Number
- NCT07129980
- Locations
- 🇺🇸
Vance Thompson Vision Clinic, Prof. LLC, Sioux Falls, South Dakota, United States
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
Not Applicable
Recruiting
- Conditions
- Myopia
- First Posted Date
- 2024-11-22
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Vance Thompson Vision
- Target Recruit Count
- 56
- Registration Number
- NCT06700460
- Locations
- 🇺🇸
Kugler Vision, Omaha, Nebraska, United States
🇺🇸Cleveland Eye Clinic, Cleveland, Ohio, United States
🇺🇸Carolina Eyecare Physicians, Mt. Pleasant, South Carolina, United States
Clinical Outcomes of Patients Implanted With the RxSight Light Adjustable Lens (LAL)
Withdrawn
- Conditions
- CataractPseudophakia
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Vance Thompson Vision
- Registration Number
- NCT06488066
- Locations
- 🇺🇸
Vance Thompson Vision, Sioux Falls, South Dakota, United States
- Prev
- 1
- 2
- 3
- Next
News
Travoprost Clinical Trials Show Promise, Uveitis Incidence Data Presented, and Gel Anesthesia for Injections
Dr. John Berdahl of Vance Thompson Vision discussed the promising clinical trial results of travoprost, offering new insights into its efficacy.